The Food and Drug Administration rescinded the emergency use authorization that made COVID-19 shots available for healthy ...

After losing nearly half its value from its 2021 highs, Pfizer stock (NYSE: PFE) now trades at about $25, presenting a potentially attractive value setup.

Parents will still be able to seek out shots from rival drugmaker Moderna, the other maker of mRNA vaccines, which has full ...

A Houston woman is suing Pfizer, claiming that their birth control Depo Provera caused her to develop a brain tumor. The Houston case is one of hundreds of suits against Pfizer making similar claims.

Questions about the COVID-19 shot abound as federal recommendations shift and medical groups issue clashing guidance.

Dr. Rana Alissa hears it daily in the clinic. “It’s better for my kid to get the virus than get the vaccine.” “The more you ...

President Trump embraced antivaccine supporters. Now a crisis is unfolding at the Centers for Disease Control and Prevention under RFK Jr.

The Food and Drug Administration gave the greenlight to updated COVID-19 shots Wednesday, maintaining unrestricted access for all Americans 65 and older while significantly limiting eligibility for ...

The Food and Drug Administration approved updated shots from Pfizer, Moderna and Novavax on Wednesday, but only for people ...

The FDA announced on Aug. 27 that it had approved updated COVID-19 vaccines, but only for certain groups of people.

A once-straightforward seasonal vaccine process has become muddled this year because of new federal guidance on who the shots are approved for. It raises questions about whether pharmacists will ...